MAP2K7 and carcinoid tumor: Since GnrH receptor expression has not been studied in larger patient collectives with carcinoid tumor disease, this raises the question whether there is an association with the above mentioned Raf-1/MEK/ERK-1/2-pathway and if its activation is dependent on GnrH receptors [52].